| Q39097827 | An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region. |
| Q38772147 | Brooke-Spiegler Syndrome and Phenotypic Variants: An Update |
| Q35571224 | CYLD GeneticTesting for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas |
| Q37448141 | CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes |
| Q37945451 | Deubiquitinases in cancer: new functions and therapeutic options. |
| Q37814068 | Deubiquitinases in the regulation of NF-κB signaling |
| Q41698209 | Development and validation of LC-MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors |
| Q91993303 | Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission |
| Q38493679 | Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours |
| Q42393322 | Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors. |
| Q49789112 | Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression |
| Q45748892 | Functional inactivation of CYLD promotes the metastatic potential of tumor epidermal cells |
| Q35289238 | Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway |
| Q34565129 | Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis |
| Q26796229 | Molecular basis of hypohidrotic ectodermal dysplasia: an update |
| Q55359925 | Multiple Facial Trichoepitheliomas and Vulval Cysts: Extending the Phenotypic Spectrum in CYLD Cutaneous Syndrome. |
| Q92407458 | Multiple Nonfamilial Unilateral Trichoepitheliomas: Report of a Case-Mini Review of the Literature |
| Q35232248 | NF-κB and cancer: a paradigm of Yin-Yang. |
| Q41001480 | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes |
| Q59460656 | The cylindromatosis (CYLD) gene and head and neck tumorigenesis |
| Q50751734 | The p38/CYLD Pathway is Involved in Necroptosis Induced by Oxygen-glucose Deprivation Combined with ZVAD in Primary Cortical Neurons. |
| Q38066196 | The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer |
| Q34111461 | Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction |
| Q37893455 | Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death |
| Q35625506 | Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling |